BioSpace News Archive

Press Releases

Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season

September 22, 2025
·
6 min read
Press Releases

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema

September 22, 2025
·
6 min read
Press Releases

TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)

September 22, 2025
·
6 min read
Press Releases

Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025

September 22, 2025
·
1 min read
Press Releases

Medical Care Technologies Inc. Launches AI Platform for Early Basal Cell Carcinoma Detection

September 22, 2025
·
1 min read
Press Releases

Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer

September 22, 2025
·
19 min read
Press Releases

TECVAYLI® and DARZALEX FASPRO®-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma

September 22, 2025
·
26 min read
Press Releases

Johnson & Johnson receives positive CHMP opinion of nipocalimab to treat a broad population of antibody-positive patients living with generalised myasthenia gravis (gMG)

September 22, 2025
·
17 min read
Press Releases

Evommune Presents Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria During Late-Breaker at EADV 2025 Congress

September 22, 2025
·
5 min read
Press Releases

Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants

September 22, 2025
·
5 min read